Tomography map of iridocorneal angles.

Source: Pablo Amil

News • Ophthalmology

The first tomography map for diagnosing glaucoma

A researcher has created an objective model that classifies the degrees of the iridocorneal angle, a key element for assessing the severity of glaucoma. With this model, ophthalmologists will have a tool to help patients make a decision when considering surgery.

Glaucoma is the leading cause of irreversible blindness worldwide. It is characterised by optic nerve degeneration and progressive peripheral vision loss. Degeneration occurs due to elevated intraocular pressure that causes changes in the iridocorneal angle.

To treat this illness, ophthalmologists establish a diagnosis and advise the patient whether to undergo surgery or not, but the final decision lies with patients, who decide exclusively based on their doctor’s advice. However, the researcher Pablo Amil, from the research group in Nonlinear Dynamics, Nonlinear Optics and Lasers (DONLL) at the Universitat Politècnica de Catalunya · BarcelonaTech (UPC), in collaboration with Ulrich Parlitz, a researcher from the Max Planck Institute for Dynamics and Self-Organization in Germany and the Instituto de Microcirugía Ocular (IMO) in Barcelona, has created a tool that will objectively show patients the severity of their glaucoma and help them make an informed decision on surgery.

Detail of the iridocorneal angle of an eye.
Detail of the iridocorneal angle of an eye.

Source: Pablo Amil

From severe to mild

This is the first tomography map for diagnosing glaucoma, which consists of 1,000 tomographic images of the iridocorneal angle acquired using optical coherence tomography (OCT) and arranged on a grid, so that patients can easily understand the condition of their eyes by identifying them somewhere between the closed-angle area (severe) and the open-angle area (mild).

According to Pablo Amil, “when it comes to diagnosing, ophthalmologists just have a single tomographic image of their patient’s eye that shows the state of the iridocorneal angle. If the angle is closed, the drainage of the intraocular fluid is blocked and intraocular pressure rises. Doctors usually give quite accurate diagnosis, but patients lack comparative tools that help them decide whether they wish to undergo surgery or not. My work will allow patients to easily and objectively compare, through an image map, the severity of their condition and help them decide on or against surgery”.

Pablo Amil, a researcher from the UPC’s research group in Non Linear...
Pablo Amil, a researcher from the UPC’s research group in Non Linear Dynamics, Nonlinear Optics and Lasers (DNOLL) in Terrassa.

A correlation similar to ophthalmologist diagnosis

Pablo Amil has created the first tomography map for diagnosing glaucoma with an artificial intelligence algorithm, to which he applied 1,000 images of iridocorneal angles. He then sorted and arranged them on a grid according to severity (severe, moderate and mild) and compared this distribution with 160 diagnoses made by ophthalmologists. The correlation result is almost the same between the map created by Amil and the severity diagnosed by ophthalmologists.

Amil’s method has been developed in the framework of the European project Be-Optical, funded by the Horizon 2020 programme and coordinated by Cristina Masoller, another researcher at the UPC campus in Terrassa. The IMO is also participating in this project, which aims to train young researchers and develop new methodologies to analyse biomedical data and contribute to the early detection of eye diseases. The project is supported by the European Regional Development Fund (ERDF) and the ICREA Acadèmia.

The UPC, the Max Planck Institute for Dynamics and Self-Organization and the IMO were granted a European patent for this work. In the medium term, Amil’s comparative model will in fact be incorporated in a new tomographic imaging technology that will instantly show patients the severity of their glaucoma. The method has recently been published in Scientific Reports, from the publishers of the journal Nature, and the three owners of the patent are already negotiating with companies in the sector to bring it to market.

Source: Universitat Politècnica de Catalunya


Read all latest stories

Related articles


Article • Transformative technology

Generative AI in healthcare: More than a chatbot

‘Computer, why did the doctor take that MRI scan of my leg? And what did it show?’: Popularized by OpenAI’s ChatGPT, generative artificial intelligence (AI) is already beginning to see…


Article • AI and DL to drive precision medicine

Diving into medical big data

Big data is transforming diagnosis and medical care, but the critical challenge remains over how to equally apply the benefits it delivers across real-world clinical settings, according to industry…


Clinical intelligence

Dedalus and Rx.Health partner to 'liberate' healthcare data

Healthcare software company Dedalus announced its strategic partnership in North America with Rx.Health, an AI-based digital health unification and clinical intelligence platform. The partnership…

Related products

Subscribe to Newsletter